By: Researcher Taymur
The genetic disease that affects the lungs and digestive system is known as cystic Fibrosis (CF). CF affects the mucus-producing cells in the body. Such liquids are meant for the body to grain and are typically slim and thin. CF densifies and binds these body fluids, allowing them to build up in the lungs, airways and digestive tract.
While medical advancements have greatly improved people with CF’s quality of life and life expectancy, the most need to deal with the situation for their entire lives. There’s actually no treatment for CF, but scientists ‘ focus is on it. Read about recent research and what people with CF might soon have.
CF research is funded, as is often the case, by committed organizations that raise funding, secure donations and compete for grants to keep researchers working on a cure. Here are currently some of the main research areas.
Some decades ago, the gene responsible for CF was identified by scientists. This contributed to the possibility that the faulty gene could be replaced in vitro by genetic replacement therapy. This treatment has nevertheless not yet succeeded.
Scientists have developed a treatment in recent years that focuses on the cause of CF instead of its symptoms. Such medications, ivacaftor (Kalydeco) and lumacaftor/ivacaftor (Orkambi), are part of a class of drugs called CFTR modulators. Such drug classes are engineered to influence and properly produce bodily fluids for the mutated gene that is responsible for CF.
In the event of earlier gene replacement therapies, a new kind of gene therapy may be discovered. This latest technique uses inhaled DNA molecules to provide the cells in the lungs with “clean,” copies of the gene. Initial tests demonstrated moderate improved symptoms in patients who used this procedure. To people with CF, this breakthrough has been very promising.
None of these therapies are the absolute cure, but many CF patients have never seen it as the first move towards disease-free life.
In general, CF problems fall into 3 groups. The following classes and complications:
These are not the only CF risks, but some of the most common: damage to airports: damage to the airways by CF. This disease, known as bronchiectasis, makes it difficult to breathe. It also makes it difficult to clear the lungs of dense, sticky mucus.
Nasal polyps: CF also leads to swelling and inflammation in the lining of your nasal tubes. Fleshy growths (polyps) can develop as a result of inflammation. Polyps make it harder to breathe.
Frequently infected: The main breeding ground for bacteria is dark, sticky mucus. This raises pneumonia and bronchitis chances.
CF impairs the digestive system’s normal functioning. These are some of the most common gastrointestinal symptoms: bowel obstruction: CF people have an increased risk of bowel obstruction due to inflammation.
Food deficiencies: CF-induced thick, sticky mucus can block the digestive system and prevent fluids that your intestines need to absorb nutrients. Nutrition moves through your digestive system without these liquids. You don’t get any food benefits. It helps you.
Diabetes: CF-generated thick, sticky mucus bruises that prevents the pancreas from working. The body can thus avoid sufficient insulin. CF can also stop the body from responding properly to insulin. All of these were diabetic complications.
CF can also cause other disorders in the body, as well as respiratory and digestive problems: Fertility problems: people with CF are almost always infertile. The consequence is that the thick mucus blocks the pipe that carries fluid from the prostate to the testes frequently. People with CF are perhaps less pregnant than non-disordered people, but many have babies.
Osteoporosis: A thin bone disease is common in people with CF. This disorder requires small bones.
Dehydration: CF makes it harder for your body to maintain a normal balance of minerals. Dehydration and electrolyte imbalance could be triggered as well.
Much of the literature on possible CF treatments is sponsored by organizations working with CF individuals and their families. Donation helps ensure that work for a cure is done. CFF is an organization accredited by a Better Business Bureau that works to fund research into rehabilitation and advanced treatments.
Cystic Fibrosis Research, Inc.: CFRI is an agency of registered charity. The main objective is to fund research, provide patients and families with resources and information, and increase awareness of CF.
Fibro Women Blogs
Chronic Woman Blogs
Chronic Illness Blogs
Official Fibromyalgia Blogs